MICHELLE EVANS: Open Payments
NPI 1952631988 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,102 in 86 payments from 18 companies in 2025. Trend: 2023 $1,512 · 2024 $2,051 · 2025 $2,102
Food & beverage: $2,033Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $490 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $255 |
| Regeneron Healthcare Solutions, Inc. | 8 | $247 |
| Amgen Inc. | 9 | $189 |
| Novartis Pharmaceuticals Corporation | 7 | $176 |
| UCB, Inc. | 5 | $129 |
| Arcutis Biotherapeutics, Inc. | 1 | $121 |
| GENZYME CORPORATION | 2 | $89 |
| Incyte Corporation | 4 | $89 |
| Janssen Biotech, Inc. | 4 | $71 |
Products named: DUPIXENT, RINVOQ, OTEZLA, ILUMYA, COSENTYX, SKYRIZI, Bimzelx, Zoryve.
Industry payments across SC — which companies pay providers there.
